IBV Valve System for the Treatment of Prolonged Air Leak Under HDE H060002 - Post Approval Study

Completed · Not applicable

Conditions studied: Prolonged Air Leak

In brief

Study to collect post-market safety data for HUD IBV Valve System, a device to control prolonged air leaks of the lung, or significant air leaks that are likely to become prolonged air leaks following lobectomy, segmentectomy, or LVRS. An air leak present on post-operative day 7 is considered prolonged unless present only during forced exhalation or cough. An air leak present on day 5 should be considered for treatment if it is: 1)continuous, 2) present during normal inhalation phase of inspiration, or 3) present upon normal expiration and accompanied by subcutaneous emphysema or respiratory compromise.

Key facts

Study ID
NCT01166516
Run by
Olympus Corporation of the Americas
People needed
32
Starts
2010-04-01
Expected to finish
2017-07-01
Last updated by the study team
2018-04-17

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.